Cargando…
Wogonin reduces cardiomyocyte apoptosis from mitochondrial release of cytochrome c to improve doxorubicin-induced cardiotoxicity
Doxorubicin (DOX) has powerful anticancer properties, but its clinical application is affected by its serious cardiotoxicity. Wogonin (WG) has been shown to have marked cardiovascular protection potential. However, it is not known whether this potential can protect the heart from DOX damage. The aim...
Autores principales: | Wei, Yunjie, Zhao, Junhao, Xiong, Jian, Chai, Jingjing, Yang, Xi, Wang, Junfeng, Chen, Jiajuan, Wang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796616/ https://www.ncbi.nlm.nih.gov/pubmed/35126708 http://dx.doi.org/10.3892/etm.2022.11128 |
Ejemplares similares
-
Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
por: Zhao, Liqun, et al.
Publicado: (2017) -
COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis
por: Zhang, Peipei, et al.
Publicado: (2023) -
Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity
por: Zhang, Xin, et al.
Publicado: (2019) -
Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis
por: Jiang, Lai, et al.
Publicado: (2020) -
Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
por: Chen, De-Shu, et al.
Publicado: (2022)